Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 89

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 89

Imaging Technology

OCTOBER 11, 2023

milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based SOFIE will continue its clinical development and commercialization program with [18F]FAPI-74 in the U.S. Financial terms were not disclosed.

Healthcare 95

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 95

Imaging Technology

APRIL 2, 2024

milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.

Healthcare 97

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 97

Imaging Technology

JULY 9, 2024

Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., Campione also joins the Blue Earth Diagnostics Ltd. Bracco Imaging S.p.A.,

Diagnostic 85

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 85

Imaging Technology

NOVEMBER 2, 2023

milla1cf Thu, 11/02/2023 - 13:52 November 2, 2023 — GE HealthCare’s Artificial Intelligence ( AI ) models predict patient response to immunotherapies with 70 to 80 percent accuracy [1] , based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer ( SITC ) in San Diego, U.S.,

Pharmaceutical 59

Pharmaceutical Healthcare Healthcare Clinic 59

Imaging Technology

OCTOBER 18, 2023

CNL will provide the starting material for irradiation and initially manage the production process during the interim scale of radiochemical grade 225Ac supply, while ITM will further process the resulting 225Ac to pharmaceutical grade under Good Manufacturing Process (GMP) specifications. Lutetium-177.

Radiopharmaceuticals 96

Radiopharmaceuticals Pharmaceutical Radiation Medical 96

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 84

Medical Radiopharmaceuticals Pharmaceutical Radiation 84